# Headache Study to Compare Aggrenox Full Dose and Reduced Dose

> **NCT00274586** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 100 (—)

## Conditions studied

- Cerebrovascular Accident

## Interventions

- **DRUG:** Aggrenox® modified release capsules
- **DRUG:** Aggrenox® modified release capsules matching placebo

## Key facts

- **NCT ID:** NCT00274586
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 100 (—)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274586, "Headache Study to Compare Aggrenox Full Dose and Reduced Dose". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00274586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*